Let's Rid Ourselves From Thomas Massie Once and for All
Federal Judge Shuts Down TN Dems Over New Congressional Map
Senate Parliamentarian Just Delivered Some Brutal News About the Reconciliation Package
Nicholas Kristof's Motte-and-Bailey Fallacy
AOC: New Leader of the Democrat Party?
A Society Without God Is a Society Without Truth
Can-Do Nation
Kamala's 'Brainstorm' Is Destroying All the Norms
Who Wins the Re-Redistricted House?
MAHA Plan for the World
America Just Told the UN to Pound Sand on Replacement Migration
Democrats’ Court-Packing Threats in Virginia Are Practice for the U.S. Supreme Court
Why Americans Support Mass Deportation but Struggle With the Process
Man Convicted of Running Chinese Police Station in Manhattan's Chinatown
FBI Offers $200K Reward for Former Air Force Agent Who Defected to Iran
Tipsheet

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order
AP Photo/Evan Vucci

President Trump signed an executive order on Monday ending current and future federal funding for gain-of-function research in certain countries, such as China and Iran.

Advertisement

The order seeks to protect Americans from this type of “dangerous” research and any lab accidents and biosecurity incidents that most likely caused the COVID-19 pandemic.

American innovation will not be impeded by the order, according to the White House, but it will increase the safety and security of biological research in the U.S.

  • For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight. Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.
  • The Biden Administration allowed dangerous gain-of-function research with insufficient levels of oversight and actively approved Federal life-science research funding in China and other countries.
  • The 2024 United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (“DURC/PEPP”) and the 2024 Framework for Nucleic Acid Synthesis Screening are the latest examples of inadequate policies that rely on self-reporting and fail to protect Americans from dangerous research practices.
  • This Order pauses research using infectious pathogens and toxins in the United States that may pose a danger to American citizens until a safer, more enforceable, and transparent policy governing such research can be developed and implemented. It directs the Director of the Office of Science and Technology Policy (OSTP) and the National Security Advisor (NSA) to work with funding agencies to develop such a policy within 120 days.
  • Unlike previous policies, this Order contains enforcement and reporting mechanisms that will strengthen oversight and discourage subjective interpretation of policies that researchers have used in the past to evade biosafety and biosecurity oversight. (White House)
Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement